Concepedia
Statistics
Publications
5
Citations
302
H-Index
Active since
1993
Affiliations
Oregon State University(Current)
National Institutes of Health
National Institute of Allergy and Infectious Diseases
V. Azarenko is an author at Oregon State University specializing in life sciences, molecular biology, and cell signaling.
Publications per year
1993–1997
The oncoprotein Bcl‐3 can facilitate NF‐kappa B‐mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
Guido Franzoso, Vincent Bours, V. Azarenko et al. · The EMBO Journal · 1993 · 177 citations · Full text
Life Sciences, Cancer Biology, Molecular Biology +10
Human RelB (I-Rel) functions as a kappa B site-dependent transactivating member of the family of Rel-related proteins.
Vincent Bours, V. Azarenko, Emmanuel Dejardin et al. · PubMed · 1994 · 39 citations
Life Sciences, Immunology, Molecular Biology +7
MHC Class II-Transfected Tumor Cells Induce Long-Term Tumor-Specific Immunity in Autologous Mice
Sivasubramanian Baskar, V. Azarenko, Elizabeth Marshall et al. · Cellular Immunology · 1994 · 39 citations
Life Sciences, Immunology, Oncology +12
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibition of fat cell differentiation
Ann E. Brodie, V. Azarenko, Ching Yuan Hu · Toxicology Letters · 1996 · 24 citations
Life Sciences, Cell Biology, Toxicology +9
Inhibition of increases of transcription factor mRNAs during differentiation of primary rat adipocytes by in vivo 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) treatment
Ann E. Brodie, V. Azarenko, Ching Yuan Hu · Toxicology Letters · 1997 · 23 citations
Life Sciences, Biochemistry, Molecular Biology +12
1–5 of 5